New4med GmbH announces first cases of its novel basivertebral nerve ablation (BVNA)

LADENBURG, Germany, July 8, 2024 /PRNewswire/ — New4med GmbHa German start-up specializing in innovative spinal treatments, announces the successful European market launch of its novel basivertebral nerve ablation (BVNA) therapy.

BVNA is a treatment for vertebrogenic pain, a type of chronic low back pain associated with bone damage to the vertebral endplates. The system, approved in Europeis a minimally invasive, implant-free procedure that can be performed on an inpatient or outpatient basis. It uses targeted radiofrequency energy to block the basivertebral nerve from transmitting pain signals to the brain, with the goal of improving function and providing long-lasting relief.

“By offering BVNA to physicians, we are providing access to this unique treatment to people suffering from spinal pain. Europe for the first time,” said Daniel SeifertShareholder and CEO designate of New4med. “Our goal is to make this high-growth therapeutic option accessible to a large population of people suffering from chronic low back pain.”

“The revolutionary ablation of the basivertebral nerve has enormous potential to help even more people with chronic pain,” the professor said. Robert PflugmacherMechernich. “Access to this form of therapy now significantly improves our treatment spectrum in the field of interventional management of chronic pain,” comments Prof. Andreas Kurthpioneer in the treatment of spinal metastases with RF technology.

“We will continue to invest in developing our infrastructure to ensure access to the broadest possible market and to meet the growing demand for this treatment,” he explained. Eric Schabershareholder and strategy consultant. “This launch is the beginning of a series of unique and highly innovative new approaches that have the potential to revolutionize current treatment options in spine surgery,” adds Eric Schaber.

About New4med
New4med GmbH is a German medical technology company specializing in the development and distribution of innovative products and procedures in spinal surgery. The product range aims to treat chronic back pain in the spinal area, thereby sustainably improving the quality of life of patients. New4med’s experienced team consists of professionals from the medical technology sector who bring their expertise and passion for innovation to the development and distribution of their products. New4med is proud to improve the quality of life of millions of people around the world.

For more information, visit our website at www.new4med.com.

Contact
Daniel Seifert
(protected email)
+49 174 – 666 66 47

Photo – https://mma.prnewswire.com/media/2454767/New4Med.jpg
Logo – https://mma.prnewswire.com/media/2454766/New4Med_Logo.jpg